This is unpublished
Scott
Tykodi
M.D.
Ph.D.
M.D.
Ph.D.
(206) 606-7763
Fred Hutchinson Cancer Center
825 Eastlake Ave E, CE2-128
Seattle, WA 98109
Physician & Research Faculty
Pinned
Academic
Associate Professor, Division of Hematology and Oncology, University of Washington
Professor, Clinical Research Division, Fred Hutchinson Cancer Center
Sites of Practice
Fred Hutchinson Cancer Center - South Lake Union
page outline
back to page outline
Photo: Fred Hutch
Education, Training, Board Certifications
- M.D., Washington University School of Medicine
- Ph.D., Washington University School of Medicine
- Residency, Barnes Jewish Hospital, Washington University School of Medicine
- Fellowship in Oncology, UW/Fred Hutch
- Medical Oncology, American Board of Internal Medicine
- Internal Medicine, American Board of Internal Medicine
Clinical Expertise
- Melanoma
- Kidney Cancer
Affiliations
- University of Washingtonwww.uwmedicine.org
- Fred Hutchinson Cancer Center - Providerwww.seattlecca.org
- Fred Hutchinson Cancer Center - Faculty & Labwww.fredhutch.org
Publications
Research and/or clinical interests
Dr. Scott Tykodi specializes in translating immunotherapy advances from the laboratory into the clinic. He has led numerous clinical trials evaluating novel, immune-based therapeutics for patients with kidney cancer and other solid tumors. Dr. Tykodi is developing a new cellular immunotherapy for kidney cancer aimed at a marker called 5T4, which is found on the surface of almost all kidney cancer cells and only rarely on healthy adult cells.